“A prospective study of clinical profile of type 2 lepra-reaction, clinical responses to treatment with thalidomide and seroprevalence of HIV in reactional patients”, J Pak Assoc Dermatol, vol. 34, no. 4, pp. 967–972, Oct. 2024, doi: 10.66344/jpad.v34i4.2717.